Atlas Trials

Treatment of Chronic Central Serous Chorioretinopathy With Open-Label Anecortave Acetate

Clinical trial NCT00489840 · COMPLETED

Trial details

NCT number
NCT00489840
Sponsor
Manhattan Eye, Ear & Throat Hospital
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Chronic Central Serous Chorioretinopathy
Start date
2007-05-01
Primary completion
2010-07-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.